Article
TMEM41B is a host factor required for the replication of diverse coronaviruses including SARS-CoV-2
27 May 2021
Abstract excerpt
Antiviral therapeutics are a front-line defense against virally induced diseases. Because viruses frequently mutate to escape direct inhibition of viral proteins, there is interest in targeting the host proteins that the virus must co-opt to complete its replication cycle. However, a detailed understanding of the interactions between the virus and the host cell is necessary in order to facilitate development of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
